Twist Bioscience's Mixed Q4: Revenue Up, Losses Persist
Update: 2025-11-14
Description
Twist Biosciences Q4 earnings report revealed a wider loss than anticipated, despite surpassing revenue expectations. The company reported a ninety-nine million dollar revenue, a seventeen percent increase from last year, but a loss per share of forty-five cents, four cents more than predicted. Investors reacted negatively to the continued losses, causing shares to drop by nine percent. Looking ahead, Twist Bioscience projects revenue growth and aims to break even by the fourth quarter of fiscal year 2026.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
